Creating a market for an innovation that kicked tradition in the tail.
Transnetyx is a molecular diagnostics company providing automated genotyping services to pharmaceutical and biotechnology companies, as well as academic laboratories.
In 2000, inferno was selected by Transnetyx – then a small start-up – to develop their initial brand and positioning platform. Since then, inferno has supported the company in every area of strategic marketing communications, and today Transnetyx is the world’s largest provider of automated genotyping services.
In 2010, inferno branded the company’s new service, Harmonyx, which provides human genetic profiling of patients to affirm drug appropriateness and dosage levels. Harmonyx is poised to become the provider of choice in the pharmacogenetics category, with inferno developing the brand positioning at each level – clinician, payor, and patient.